1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-324

PAR-25-324National Institutes of HealthR37

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Jan 6, 2025

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 1 standing review criteria here, free with an account. Create free account

Summary

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs) who qualify for conversion based on receiving a percentile within the NCI payline for established investigators on their R01 applications…

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 1 standing review criteria National Institutes of Health applies to this kind of proposal (its standard framework, not criteria written for this announcement)

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-057National Institutes of Health6 review criteria on file

—

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

RFA-DK-27-108National Institutes of Health3 review criteria on fileagency framework

$500k

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-27-139National Institutes of Health

—

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

RFA-DK-27-112National Institutes of Health

—

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Cancer), with at least two weeks to apply.

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

RFA-CA-27-001National Institutes of Health4 review criteria on file

$150k

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-27-002National Institutes of Health4 review criteria on fileagency framework

$300k

Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)

PAR-27-025National Institutes of Health7 review criteria on fileagency framework

—

Everything open tagged Cancer

Hiring in this research area now

All oncology jobs

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-25-324.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.